Alexandria Real Estate Equities (ARE) FY2025 10-K Annual Report
Alexandria Real Estate Equities (ARE) 10-K annual report for fiscal year 2025, filed with SEC EDGAR on Jan 26, 2026. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.
Alexandria Real Estate Equities FY2025 10-K Analysis
Business Overview
- • Life science REIT focused on owning, operating, developing collaborative Megacampus™ ecosystems in top U.S. innovation clusters
- • Emphasis on Class A/A+ property development with 3.5 million RSF under construction as of December 31, 2025
Management Discussion & Analysis
- • Revenue from acquired below-market lease amortization: $41.3M in 2025 vs $89.4M in 2024, indicating a significant YoY decrease
- • Impairment charges totaled $2.20B in 2025 impacting multiple markets, highlighting valuation pressure on real estate assets
Risk Factors
- • Regulatory/legal risk: SEC scrutiny of impairment recognition and valuation assumptions for real estate and non-real estate investments affecting financial reporting accuracy
- • Geopolitical/macroeconomic risk: Real estate asset impairments surged to $2.2B in 2025, indicating vulnerability to macroeconomic shifts impacting tenant demand and property values
Alexandria Real Estate Equities FY2025 Key Financial MetricsXBRL
Revenue
$3.0B
▼ -2.9% YoY
Net Income
-$1.4B
▼ -542.7% YoY
Net Margin
-47.2%
▼ -5760bp YoY
ROE
-9.2%
▼ -1105bp YoY
Total Assets
$34.1B
▼ -9.2% YoY
EPS (Diluted)
$-8.44
▼ -568.9% YoY
Operating Cash Flow
$1.4B
▼ -6.0% YoY
Source: XBRL data from Alexandria Real Estate Equities FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on Alexandria Real Estate Equities
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.